Third Rock Ventures, LLC

Q3 2015 13F Holdings

  • Location
    boston, MA
  • Num holdings

    5

  • Value ($000)

    $1,071,141

  • Date Filed
    11/03/2015
  • Form type
    13F-HR
  • CIK
    0001600135
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2015 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
GBT
GBT

GLOBAL BLOOD THERAPEUTICS IN

COM
$622.32M
58 %

14,760,900

SAGE
SAGE

SAGE THERAPEUTICS INC

COM
$272.66M
26 %

6,442,916

BPMC
BPMC

BLUEPRINT MEDICINES CORP

COM
$157.77M
15 %

7,393,059

---

ELEVEN BIOTHERAPEUTICS INC

COM
$11.67M
1 %

4,841,591

ZFGNUSD
ZFGNUSD

ZAFGEN INC

COM
$6.72M
1 %

210,371

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 5 of 5